Biotech ETFs Lead Tech Gains
The tech-focused exchange-traded funds
rose Friday with the biotech-focused ETFs leading the way.
The Biotech HOLDR
(
BBH |
Quote |
Chart |
News |
PowerRating) rose 4.6%,
the Nasdaq Biotechnology iShares
(
IBB |
Quote |
Chart |
News |
PowerRating) 3.7%. Among their components, Genzyme
General
(
GENZ |
Quote |
Chart |
News |
PowerRating) upped its 2001 sales forecast for kidney dialysis medicine
Renagel. Gilead Sciences
(
GILD |
Quote |
Chart |
News |
PowerRating) said it has applied for European regulatory
clearance to sell a treatment for HIV. Component IDEC Pharmaceuticals
(
IDPH |
Quote |
Chart |
News |
PowerRating) jumped 15.2%.
The Wireless HOLDR
(
WMH |
Quote |
Chart |
News |
PowerRating) gained
3.6%, the B2B Internet HOLDR
(
BHH |
Quote |
Chart |
News |
PowerRating) 2.9%, the Internet HOLDR
(
HHH |
Quote |
Chart |
News |
PowerRating) 2.8%,
the Software HOLDR
(
SWH |
Quote |
Chart |
News |
PowerRating) 2.8%, the Nasdaq 100 Tracking Stock
(
QQQ |
Quote |
Chart |
News |
PowerRating) 2.6%,
the Dow Jones Technology iShares
(
IYW |
Quote |
Chart |
News |
PowerRating) 2.4%.
